Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,225 | 22 | 99.6% |
| Travel and Lodging | $5.38 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $290.31 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $239.66 | 2 | $0 (2024) |
| Novo Nordisk Inc | $161.79 | 4 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $156.65 | 2 | $0 (2024) |
| Lilly USA, LLC | $147.39 | 3 | $0 (2024) |
| Amgen Inc. | $131.12 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $57.31 | 3 | $0 (2024) |
| Cranial Technologies, Inc | $17.39 | 1 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $14.79 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.92 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $742.20 | 13 | AstraZeneca Pharmaceuticals LP ($239.66) |
| 2023 | $471.45 | 9 | GlaxoSmithKline, LLC. ($290.31) |
| 2022 | $16.68 | 1 | Merck Sharp & Dohme LLC ($16.68) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.63 | General |
| 06/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.83 | General |
| Category: Respiratory | ||||||
| 05/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $126.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Diabetes | ||||||
| 02/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.81 | General |
| 02/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: VACCINE | ||||||
| 01/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: Diabetes | ||||||
| 01/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Cardio-renal | ||||||
| 01/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.50 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $5.38 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: DIABETES | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: Inflammation | ||||||
| 09/05/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Inflammation | ||||||
| 08/29/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $123.06 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: VACCINES | ||||||
| 06/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2023 | Merck Sharp & Dohme LLC | ROTATEQ (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: VACCINE | ||||||
| 05/23/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: VACCINES | ||||||
| 01/04/2023 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: Cranial Orthotic | ||||||
| 11/09/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLUJAN | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 43 | 59 | $59,500 | $4,950 |
| 2021 | 2 | 26 | 55 | $12,551 | $5,388 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 30 | $24,000 | $1,989 | 8.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 16 | $16,000 | $1,546 | 9.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $19,500 | $1,415 | 7.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 44 | $8,976 | $3,845 | 42.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $3,575 | $1,542 | 43.1% |
About Dr. Heidi Pang, DO
Dr. Heidi Pang, DO is a Family Medicine healthcare provider based in Panorama City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2017. The National Provider Identifier (NPI) number assigned to this provider is 1790213494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heidi Pang, DO has received a total of $1,230 in payments from pharmaceutical and medical device companies, with $742.20 received in 2024. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,225).
As a Medicare-enrolled provider, Pang has provided services to 69 Medicare beneficiaries, totaling 114 services with total Medicare billing of $10,338. Data is available for 2 years (2021–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Panorama City, CA
- Active Since 05/25/2017
- Last Updated 10/25/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1790213494
Products in Payments
- VOQUEZNA (Drug) $156.65
- AREXVY (Drug) $146.42
- BEXSERO (Biological) $143.89
- Otezla (Drug) $131.12
- MOUNJARO (Drug) $126.88
- BREZTRI (Drug) $119.83
- FARXIGA (Drug) $119.83
- GARDASIL (Biological) $21.92
- JARDIANCE (Drug) $20.51
- ROTATEQ (Biological) $18.71
- Rybelsus (Drug) $17.67
- Doc Band (Device) $17.39
- BELSOMRA (Drug) $16.68
- Kerendia (Drug) $14.79
- TRADJENTA (Drug) $13.92
- Ozempic (Drug) $5.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Panorama City
Mrs. Shovek Boyadjian
Family Medicine — Payments: $11,818
Reyadh Michail, M.d, M.D
Family Medicine — Payments: $9,576
Jose Elacion, M.d, M.D
Family Medicine — Payments: $1,953
Nana Barseghian, Md, MD
Family Medicine — Payments: $1,617
Dr. Arash Karimi Afshar, Do, DO
Family Medicine — Payments: $744.10
Robert Meyerson, Md, MD
Family Medicine — Payments: $719.82